Corcept Therapeutics Announces Second Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update
Go back to Corcept Therapeutics Announces Second Quarter 2017 Financial Results, Raises 2017 Revenue Guidance and Provides Corporate Update| Corcept Therapeutics, Inc. (NASDAQ: CORT) | Delayed: 79.85 +0.14 (0.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.71 | 52 Week High | $10.00 | |||
| Open | $80.03 | 52 Week Low | $3.22 | |||
| Day High | $82.31 | P/E | N/A | |||
| Day Low | $79.22 | EPS | $-0.46 | |||
| Volume | 947,294 | |||||
